Ultrasound imaging was validated for the detection of pancreas inflammation in living rats during the development of type 1 diabetes. The technology could be used clinically for non-invasive TD1 risk prediction prior to autoimmunity or to assess the effectiveness of potential therapeutics in future experiments.